← Back to 2-MMC

2-MMC Stats & Data

Stimulant Research-chemical

Ortho 2-methyl mc Orthophedrone Orthomephedrone 2mmc ortomephedrone 2-methylmethcathinone 2methylmethcathinone

NPS DataHub

MW213.71

FormulaC11H16ClNO

CAS1246815-51-9

IUPAC(2RS)-2-(Methylamino)-1-(2-methylphenyl)propan-1-one

SMILES[Cl-].CNC(C)C(=O)c1ccccc1C.[H+]

InChIKeyBNZJHCPXDZXUMH-UHFFFAOYSA-N

Phenethylamines; Cathinones; 2020/1. Von 2-Phenethylamin abgeleitete Verbindungen; 2021/1. Von 2-Phenethylamin abgeleitete Verbindungen; 2022/1. Von 2-Phenethylamin abgeleitete Verbindungen

Chemical Class Cathinone

Psychoactive Class Stimulant / Entactogen

Receptor Profile

Receptor Actions

Inhibitors

Dopamine-norepinephrine reuptake inhibitor (higher affinity for DAT and NET than SERT)

Other

Serotonin-norepinephrine-dopamine releasing agent (SNDRA)

History & Culture

2-Methylmethcathinone emerged as a novel psychoactive substance during the mid-2010s wave of synthetic cathinone proliferation. The compound was first identified by Swedish authorities in 2014, representing one of the later positional isomers of mephedrone to appear on the recreational drug market. Following its initial detection in Sweden, 2-MMC subsequently spread to other European countries, with reports of its presence emerging from Poland and Spain. As a structural relative of the more widely known mephedrone (4-MMC) and 3-methylmethcathinone (3-MMC), 2-MMC appeared during a period when cathinone derivatives were being systematically explored by clandestine chemists seeking legal alternatives to controlled stimulants. The compound has remained relatively obscure compared to its positional isomers, which gained greater prominence in both recreational use and regulatory attention.

Effect Profile

Curated + 4 Reports

Empathogen 4.7

Strong sensory enhancement with moderate stimulation, mild euphoria, low empathy

Empathy / Social Openness×3

Euphoria / Mood Elevation×2

Stimulation×1

Sensory Enhancement×1

Stimulant 5.5

Moderate euphoria, anxiety/jitters, and focus with mild stimulation

Stimulation / Energy×3

Euphoria / Mood Lift×2

Focus / Productivity×2

Anxiety / Jitters×1

Based on reports from:

Erowid Experience Reports PsychonautWiki 2-MMC

Tolerance & Pharmacokinetics

drugs.wiki

Tolerance Decay

Full tolerance 1h Half tolerance 4d Baseline ~5d

Experience Report Analysis

Erowid

4 Reports

2016–2025 Date Range

4 With Age Data

4 Effects Detected

Demographics

Gender Distribution

Age Distribution

Reports Over Time

Effect Analysis

Erowid

Effects aggregated from 4 experience reports (4 Erowid)

4 Reports

4 Effects Detected

4 Positive

0 Adverse

0 Neutral

Effect Sentiment Distribution

Confidence Distribution

Positive Effects 4

Euphoria 75.0% 70%

Music Enhancement 75.0% 70%

Focus Enhancement 75.0% 70%

Stimulation 75.0% 70%

Adverse Effects 0

Form / Preparation

Most common forms and preparations reported

Read full reports on Erowid →

Legal Status

Country	Status	Notes
Germany	NpSG (controlled)	Controlled under the Neue-psychoaktive-Stoffe-Gesetz (New Psychoactive Substances Act). Sale, production with intent to sell, and administration to others are criminal offenses. Possession is prohibited but not subject to criminal penalties.
Poland	Illegal (Group I-P)	Prohibited as a psychotropic substance under Group I-P. Although not explicitly named in scheduling lists, it is controlled as an isomer of 3-MMC and mephedrone (4-MMC), which are scheduled substances.
United Kingdom	Class B	Controlled under the Misuse of Drugs Act 1971. Class B substances carry penalties of up to 5 years imprisonment for possession and up to 14 years for supply or production.
United States	Schedule I	Controlled under the Controlled Substances Act as a hallucinogenic substance. Regulated as a positional isomer of mephedrone (4-MMC), which places it automatically under Schedule I classification.